Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380715060> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4380715060 abstract "Background: Klotho is an anti-aging protein expressed primarily in the kidney and vasculature. Chronic kidney disease (CKD) results in hyperphosphatemia. We reported that high levels of phosphate downregulate Klotho expression in vascular cells. Endothelial-to-mesenchymal transition (EndMT) in arteries promotes the development of atherosclerosis, and CKD is a significant risk factor for atherosclerosis. However, the impact of CKD on EndMT in arteries is unclear and whether Klotho insufficiency plays a role in the mechanism underlying vascular EndMT remains unknown. This study tested the hypothesis that Klotho insufficiency associated with CKD induces senescence in arterial endothelial cells to upregulate EndMT. Methods and Results: We developed a CKD model in C57/BL6 mice (5-6 months old) on AIN-76A diet and treated with adenine and calcitriol. CKD was confirmed by markedly elevated blood levels of creatinine and phosphate, as well as by renal tubular damage. En face immunofluorescence staining of aorta and image quantification revealed that the levels of biomarkers of senescence (P21) and EndMT (vimentin) were greater, while Klotho levels were lower, in the aortic arch endothelial cells of CKD mice compared to sham control mice. P21 and vimentin were co-localized in a greater number of endothelial cells in the aortic arch of CKD mice. High phosphate treatment upregulated the levels of P21 and vimentin and reduced the levels of Klotho in both primary human and mouse aortic endothelial cells, and knockdown P21 attenuated EndMT induced by high phosphate. Recombinant Klotho suppressed both senescence and EndMT in primary human aortic endothelial cells. Further, prolonged treatment of CKD mice with recombinant Klotho attenuated endothelial senescence and EndMT in the aortic arch. Conclusion: Klotho insufficiency associated with CKD promotes endothelial senescence and EndMT in aorta. High phosphate is capable of inducing endothelial senescent change that provokes EndMT. Administration of recombinant Klotho or upregulation of Klotho expression may have therapeutic potential for suppressing pro-atherosclerosis activity in large arteries by prevention of endothelial senescence and resultant EndMT." @default.
- W4380715060 created "2023-06-15" @default.
- W4380715060 creator A5000079670 @default.
- W4380715060 creator A5011806768 @default.
- W4380715060 creator A5026837965 @default.
- W4380715060 creator A5047927833 @default.
- W4380715060 creator A5069922286 @default.
- W4380715060 creator A5080309923 @default.
- W4380715060 date "2022-11-08" @default.
- W4380715060 modified "2023-10-14" @default.
- W4380715060 title "Abstract 13254: Klotho Suppresses Endothelial-to-Mesenchymal Transition in the Aorta of Mice With Chronic Kidney Disease by Inhibition of Endothelial Senescent Activity" @default.
- W4380715060 doi "https://doi.org/10.1161/circ.146.suppl_1.13254" @default.
- W4380715060 hasPublicationYear "2022" @default.
- W4380715060 type Work @default.
- W4380715060 citedByCount "0" @default.
- W4380715060 crossrefType "journal-article" @default.
- W4380715060 hasAuthorship W4380715060A5000079670 @default.
- W4380715060 hasAuthorship W4380715060A5011806768 @default.
- W4380715060 hasAuthorship W4380715060A5026837965 @default.
- W4380715060 hasAuthorship W4380715060A5047927833 @default.
- W4380715060 hasAuthorship W4380715060A5069922286 @default.
- W4380715060 hasAuthorship W4380715060A5080309923 @default.
- W4380715060 hasConcept C104317684 @default.
- W4380715060 hasConcept C126322002 @default.
- W4380715060 hasConcept C127561419 @default.
- W4380715060 hasConcept C134018914 @default.
- W4380715060 hasConcept C147447768 @default.
- W4380715060 hasConcept C204232928 @default.
- W4380715060 hasConcept C2778653478 @default.
- W4380715060 hasConcept C2780091579 @default.
- W4380715060 hasConcept C522857546 @default.
- W4380715060 hasConcept C55493867 @default.
- W4380715060 hasConcept C71924100 @default.
- W4380715060 hasConcept C86803240 @default.
- W4380715060 hasConcept C9832595 @default.
- W4380715060 hasConceptScore W4380715060C104317684 @default.
- W4380715060 hasConceptScore W4380715060C126322002 @default.
- W4380715060 hasConceptScore W4380715060C127561419 @default.
- W4380715060 hasConceptScore W4380715060C134018914 @default.
- W4380715060 hasConceptScore W4380715060C147447768 @default.
- W4380715060 hasConceptScore W4380715060C204232928 @default.
- W4380715060 hasConceptScore W4380715060C2778653478 @default.
- W4380715060 hasConceptScore W4380715060C2780091579 @default.
- W4380715060 hasConceptScore W4380715060C522857546 @default.
- W4380715060 hasConceptScore W4380715060C55493867 @default.
- W4380715060 hasConceptScore W4380715060C71924100 @default.
- W4380715060 hasConceptScore W4380715060C86803240 @default.
- W4380715060 hasConceptScore W4380715060C9832595 @default.
- W4380715060 hasIssue "Suppl_1" @default.
- W4380715060 hasLocation W43807150601 @default.
- W4380715060 hasOpenAccess W4380715060 @default.
- W4380715060 hasPrimaryLocation W43807150601 @default.
- W4380715060 hasRelatedWork W2020449916 @default.
- W4380715060 hasRelatedWork W2025703417 @default.
- W4380715060 hasRelatedWork W2042033030 @default.
- W4380715060 hasRelatedWork W2075088231 @default.
- W4380715060 hasRelatedWork W2079370847 @default.
- W4380715060 hasRelatedWork W2107729314 @default.
- W4380715060 hasRelatedWork W2127085070 @default.
- W4380715060 hasRelatedWork W2157270415 @default.
- W4380715060 hasRelatedWork W2409608972 @default.
- W4380715060 hasRelatedWork W4220896095 @default.
- W4380715060 hasVolume "146" @default.
- W4380715060 isParatext "false" @default.
- W4380715060 isRetracted "false" @default.
- W4380715060 workType "article" @default.